BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 8096629)

  • 21. New views on synapse-glia interactions.
    Pfrieger FW; Barres BA
    Curr Opin Neurobiol; 1996 Oct; 6(5):615-21. PubMed ID: 8937825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutamate synapses and receptors on insect muscle.
    Usherwood PN
    Adv Biochem Psychopharmacol; 1981; 27():183-93. PubMed ID: 6108693
    [No Abstract]   [Full Text] [Related]  

  • 23. Transmitter release from sympathetic nerve terminals on an impulse-by-impulse basis and presynaptic receptors.
    Brock JA; Cunnane TC
    Ann N Y Acad Sci; 1990; 604():176-87. PubMed ID: 1977347
    [No Abstract]   [Full Text] [Related]  

  • 24. Neurotransmitter release mechanisms in sympathetic and parasympathetic nerve terminals.
    Searl TJ; Cunnane TC
    Biochem Soc Trans; 1993 May; 21(2):416-20. PubMed ID: 8103006
    [No Abstract]   [Full Text] [Related]  

  • 25. Enlightening the postsynaptic density.
    Ziff EB
    Neuron; 1997 Dec; 19(6):1163-74. PubMed ID: 9427241
    [No Abstract]   [Full Text] [Related]  

  • 26. Synaptic mechanisms of bipolar cell terminals.
    Matthews G
    Vision Res; 1999 Jul; 39(15):2469-76. PubMed ID: 10396616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The importance of synapsin I and II for neurotransmitter levels and vesicular storage in cholinergic, glutamatergic and GABAergic nerve terminals.
    Bogen IL; Haug KH; Roberg B; Fonnum F; Walaas SI
    Neurochem Int; 2009; 55(1-3):13-21. PubMed ID: 19428802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computer modeling of synapsin I binding to synaptic vesicles and F-actin: implications for regulation of neurotransmitter release.
    Benfenati F; Valtorta F; Greengard P
    Proc Natl Acad Sci U S A; 1991 Jan; 88(2):575-9. PubMed ID: 1671174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Enzymatic methods for the identification of a transmitter substance in a specific brain nucleus (author's transl)].
    Kataoka K; Sorimachi M
    Tanpakushitsu Kakusan Koso; 1974 Jul; 19(7):537-49. PubMed ID: 4154482
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of activity in the development of phasic and tonic synaptic terminals.
    Lnenicka GA
    Ann N Y Acad Sci; 1991; 627():197-211. PubMed ID: 1679308
    [No Abstract]   [Full Text] [Related]  

  • 31. [Modulatory effects of various factors of muscular origin on the function of the motor nerve endings].
    Drabkina TM; Matiushkin DP; RomanovskiÄ­ DIu
    Ross Fiziol Zh Im I M Sechenova; 1999 Jan; 85(1):149-58. PubMed ID: 10389172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of the enhancement in transmitter release from central and peripheral noradrenergic nerve terminals induced by the purified scorpion venom, tityustoxin.
    Alder-Graschinsky E; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Jul; 303(3):243-9. PubMed ID: 28487
    [No Abstract]   [Full Text] [Related]  

  • 33. Double barrier quantal model of neurotransmitter release.
    Melkonian DS
    Neuroreport; 1991 Nov; 2(11):719-22. PubMed ID: 1687358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-uniform changes in nerve-terminal calcium homeostasis during aging.
    Smith DO
    Neurobiol Aging; 1987; 8(4):366-8. PubMed ID: 2888033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On the contribution of mathematical models to the understanding of neurotransmitter release.
    Parnas H; Parnas I; Segel LA
    Int Rev Neurobiol; 1990; 32():1-50. PubMed ID: 1981883
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabolic regulation in the release and action of excitatory and inhibitory amino acids in the central nervous system.
    Watkins JC
    Biochem Soc Symp; 1972; (36):33-47. PubMed ID: 4155630
    [No Abstract]   [Full Text] [Related]  

  • 37. Characteristics of calcium transient in different parts of frog nerve terminal in response to nerve impulse.
    Samigullin DV; Vasin AL; Bukharaeva EA; Nikolsky EE
    Dokl Biol Sci; 2010; 431():83-5. PubMed ID: 20506840
    [No Abstract]   [Full Text] [Related]  

  • 38. Neurotransmitters.
    Hyman SE
    Curr Biol; 2005 Mar; 15(5):R154-8. PubMed ID: 15753022
    [No Abstract]   [Full Text] [Related]  

  • 39. Neuroactivity of detonation nanodiamonds: dose-dependent changes in transporter-mediated uptake and ambient level of excitatory/inhibitory neurotransmitters in brain nerve terminals.
    Pozdnyakova N; Pastukhov A; Dudarenko M; Galkin M; Borysov A; Borisova T
    J Nanobiotechnology; 2016 Mar; 14():25. PubMed ID: 27036406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A bioenergetic approach to the nerve terminal.
    Nicholls D
    Biochim Biophys Acta; 1992 Jul; 1101(2):264-5. PubMed ID: 1352992
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.